The World Health Organization Classification of Neoplasms of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting ??? Airlie House, Virginia, November, 1997, The Hematology Journal, vol.1, issue.1, pp.53-66, 1997. ,
DOI : 10.1038/sj.thj.6200013
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma, Journal of Clinical Oncology, vol.27, issue.4, pp.511-519, 2009. ,
DOI : 10.1200/JCO.2008.16.8435
Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype, Leukemia, vol.15, issue.11, pp.1785-91, 2001. ,
DOI : 10.1038/sj.leu.2402272
Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis, Hematological Oncology, vol.48, issue.5, pp.365-80, 1989. ,
DOI : 10.1002/hon.2900070505
Patterns of survival in mantle cell lymphoma, Annals of Oncology, vol.6, issue.3, pp.257-62, 1995. ,
DOI : 10.1093/oxfordjournals.annonc.a059155
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants., Journal of Clinical Oncology, vol.15, issue.4, pp.1664-71, 1997. ,
DOI : 10.1200/JCO.1997.15.4.1664
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group., Journal of Clinical Oncology, vol.16, issue.5, pp.1922-1952, 1998. ,
DOI : 10.1200/JCO.1998.16.5.1922
Sequential chemotherapy regimens followed by highdose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study, Haematologica, vol.89, issue.10, pp.1275-1281, 2004. ,
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma., Journal of Clinical Oncology, vol.16, issue.12, pp.3803-3812, 1998. ,
DOI : 10.1200/JCO.1998.16.12.3803
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study, Leukemia, vol.16, issue.4, pp.587-93, 2002. ,
DOI : 10.1038/sj.leu.2402406
High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience, Bone Marrow Transplantation, vol.22, issue.7, pp.645-50, 1998. ,
DOI : 10.1038/sj.bmt.1701400
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission., Journal of Clinical Oncology, vol.16, issue.1, pp.13-21, 1998. ,
DOI : 10.1200/JCO.1998.16.1.13
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant, European Journal of Haematology, vol.96, issue.2, pp.73-80, 2003. ,
DOI : 10.1016/S1535-6108(03)00028-X
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries, British Journal of Haematology, vol.6, issue.5 ,
DOI : 10.1038/sj.bmt.1701400
Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantlecell lymphoma: a matched pair analysis ,
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network, Blood, vol.105, issue.7, pp.2677-84, 2005. ,
DOI : 10.1182/blood-2004-10-3883
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group, Blood, vol.112, issue.7, pp.2687-93, 2008. ,
DOI : 10.1182/blood-2008-03-147025
Treatment of mantle-cell lymphomas with the VAD +/chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation, Annals of Oncology, vol.8, issue.1+, pp.103-109, 1997. ,
DOI : 10.1023/A:1008278522789
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma, Blood, vol.111, issue.2, pp.558-65, 2008. ,
DOI : 10.1182/blood-2007-06-095331
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas, Journal of Clinical Oncology, vol.17, issue.4, p.1244, 1999. ,
DOI : 10.1200/JCO.1999.17.4.1244
Revised Response Criteria for Malignant Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.579-86, 2007. ,
DOI : 10.1200/JCO.2006.09.2403
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG), Journal of Clinical Oncology, vol.23, issue.9, pp.1984-92, 2005. ,
DOI : 10.1200/JCO.2005.08.133
Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival, Journal of Clinical Oncology, vol.20, issue.5, pp.1288-94, 2002. ,
DOI : 10.1200/JCO.2002.20.5.1288
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine, Journal of Clinical Oncology, vol.23, issue.28, pp.7013-7036, 2005. ,
DOI : 10.1200/JCO.2005.01.1825
Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma, Haematologica, vol.91, issue.3, pp.425-431, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00452943
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen), Blood, vol.102, issue.2, pp.749-55, 2003. ,
DOI : 10.1182/blood-2002-08-2476
Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma, Journal of Clinical Oncology, vol.23, issue.15, pp.3383-3392, 2005. ,
DOI : 10.1200/JCO.2005.08.100
Bendamustine Plus Rituximab Is Superior in Respect of Progression Free Survival and CR Rate When Compared to CHOP Plus Rituximab as First-Line Treatment of Patients with Advanced Follicular, Indolent, and Mantle Cell Lymphomas: Final Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Blood, vol.114, p.168, 2009. ,
Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma, Leukemia & Lymphoma, vol.24, issue.8, pp.1-10, 2009. ,
DOI : 10.1056/NEJMra0708875
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome, Haematologica, vol.92, issue.1 ,
DOI : 10.3324/haematol.10608
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma, Bone Marrow Transplantation, vol.102, issue.8, pp.529-563, 2008. ,
DOI : 10.1038/bmt.2008.201
Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma, Journal of Clinical Oncology, vol.27, issue.26, pp.4365-70, 2009. ,
DOI : 10.1200/JCO.2008.21.3116
Ki- 67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network, J Hematop, 2009. ,
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group, Blood, vol.111, issue.4, pp.2385-2392, 2008. ,
DOI : 10.1182/blood-2007-10-117010
Nonablative Allogeneic Stem-Cell Transplantation for Advanced/Recurrent Mantle-Cell Lymphoma, Journal of Clinical Oncology, vol.21, issue.23 ,
DOI : 10.1200/JCO.2003.05.501
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma, Blood, vol.104, issue.12, pp.3535-3577, 2004. ,
DOI : 10.1182/blood-2004-06-2275
Hematopoietic stem cell transplantation in mantle cell lymphoma, Annals of Oncology, vol.16, issue.4, pp.618-642, 2005. ,
DOI : 10.1093/annonc/mdi107
Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma, Leukemia & Lymphoma, vol.62, issue.3, pp.447-50, 2008. ,
DOI : 10.1182/blood-2005-04-1422